Shepherd Ave Capital Acquisition Corporation (SPHAU) Prices $75M IPO
by Nicholas Alan Clayton on 2024-12-04 at 5:06pm

Shepherd Ave Capital Acquisition Corporation (NASDAQ:SPHAU) announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “SPHAU”, Thursday, December 5, 2024.

The new SPAC intends to conduct a broad search for a combination target without a preference for a specific industry or region.

Shepherd Ave Capital’s sponsor team is led by Chief Executive Officer, Chairman and Director William W. Snyder and Chief Financial Officer and Director Jia Peng. Evan M. Graj, Stephen Markscheid and Wee Peng Siong will serve on its Board of Directors.

Total SPAC deal count for 2024 year-to-date is now 52. This offering is expected to close on Friday December 6, 2024.


SPAC Advisory Partners LLC (“SAP”), a division of Kingswood Capital Partners, LLC, is acting as the sole book running manager for the initial public offering. Robinson+Cole is serving as Issuer’s Counsel with Winston & Strawn LLP serving as Underwriter’s Counsel. MaloneBailey LLP serves as auditor. Wilmington Trust, N.A. is acting as trustee.

Recent Posts
by Nicholas Alan Clayton on 2024-12-24 at 2:07pm

Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...

by Nicholas Alan Clayton on 2024-12-24 at 8:13am

At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...

by Nicholas Alan Clayton on 2024-12-23 at 3:40pm

Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...

by Kristi Marvin on 2024-12-23 at 10:52am

Translational Development Acquisition Corp. (NASDAQ: TDACU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TDACU”, Monday, December 23, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but intend to focus on industries that...

by Nicholas Alan Clayton on 2024-12-23 at 8:18am

At the SPAC of Dawn SPACs have set to have a busy holiday week with three business combination approval votes and eight special meetings for extensions. Teams are trying to get eight of these in the books today, including all three completion votes ahead of Christmas Eve tomorrow. As noted last week, the theme of...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved